Tumori

Keyphrases

Publications

2024

Pamela Milito, Guglielmo Niccolò Piozzi, Mohammad Iqbal Hussain, Tommaso A Dragani, Luca Sorrentino, Maurizio Cosimelli, Marcello Guaglio, Luigi Battaglia
Effect of neoadjuvant chemoradiation on anorectal function assessed with anorectal manometry: A systematic review and meta-analysis. Tumori (2024)
Lauro Bucchi, Silvia Mancini, Federica Zamagni, Emanuele Crocetti, Luigino Dal Maso, Stefano Ferretti, Flavia Baldacchini, Orietta Giuliani, Alessandra Ravaioli, Rosa Vattiato, Francesca Bella, Giuliano Carrozzi, Giuseppe Cascone, Margherita Ferrante, Maria Michiara, Antonino Musolino, Rosario Tumino, Antonella Usticano, Alessandra Allotta, Sebastiano Pollina Addario, Francesco Lacarrubba, Ignazio Stanganelli, Fabio Falcini
North-south differences in incidence and surveillance of cutaneous malignant melanoma in Italy. Tumori (2024)
C L Deantoni, I Dell'Oca
In reply to Topkan et al. Tumori (2024)
Pierre Cornillon, Wafa Bouleftour, Thomas Reynaud, Gregoire Pigne, Denis Maillet, Salima Hamizi, Marie Beguinot
Immunogenicity of radiotherapy on bone metastases from prostate adenocarcinoma: What is the future for the combination with radiotherapy/immunotherapy? Tumori (2024)
Valeria Cognigni, Enrica Capelletto, Paola Bordi, Valeria Pavese, Federica Maria Carfì, Francesco Gelsomino, Andrea De Giglio, Rita Chiari, Roberta Minari, Enrico Ambrosini, Antonio Percesepe, Daniela Giachino, Paolo Bironzo, Marcello Tiseo
A case series of non-small cell lung cancer patients with EGFR or HER2 exon 20 insertion in Li Fraumeni syndrome. Tumori (2024)
Luca Sorrentino, Andrea Scardino, Luigi Battaglia, Raffaella Vigorito, Giovanna Sabella, Filippo Patti, Michele Prisciandaro, Elena Daveri, Alessandro Gronchi, Filiberto Belli, Marcello Guaglio
Outcomes of chemotherapy/chemoradiation vs. R2 surgical debulking vs. palliative care in nonresectable locally recurrent rectal cancer. Tumori (2024)
Andrea C Ferrari, Teresa Perillo, Giuseppe Maria Milano, Matteo Silva, Chiara Rutigliano, Andrea Salvo, Virginia Livellara, Massimo Conte, Luca Coccoli, Elena Amore, Marta Pierobon, Francesco Vietina, Elena Pagani Bagliacca, Marco Spinelli, Maria Speranza Massei, Valentina Massetti, Elena Legnani, Ilaria Puglisi, Giulia Zucchetti, Paola Quarello
The power of art and the powers of adolescents with cancer: Age-specific projects at Italian pediatric oncology centers. Tumori (2024)
Luca Agnelli, Andrea Villa, Fouziah Butt, Matteo Duca, Alessandro Guidi, Marcello Carapezza, Michele Addante, Gaetano Lenoci, Paul O'Regan, Laura Russo, Sara Cresta, Alessandra Castano, Elisabella Ebrahem, Sara Alfieri, Akshita Patil, Louise Carter, Caroline Dive, Filippo Guglielmo De Braud, Silvia Damian
PROACT 2.0: A new open-source tool to improve patient-doctor communication in clinical trials. Tumori (2024)
Rita Leporati, Daniela Miliziano, Teresa Beninato, Laura Mazzeo, Sara Manglaviti, Marta Brambilla, Mario Alberto Occhipinti, Arsela Prelaj, Claudia Proto, Giuseppe Lo Russo
Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs. Tumori (2024)
Giulia Marvaso, Angelo Vitullo, Giulia Corrao, Maria Giulia Vincini, Mattia Zaffaroni, Riccardo Villa, Federico Mastroleo, Lukasz Kuncman, Dario Zerini, Ilaria Repetti, Chiara Lorubbio, Gennaro Musi, Ottavio De Cobelli, Barbara Alicja Jereczek-Fossa
Muscle-invasive bladder cancer in elderly and frail people: Is hypofractionated radiotherapy a feasible approach when no other local options are available? Tumori (2024)
Antonio Silvani, Enrico Franceschi
A new era after a long wait: Vorasetinib, an inhibitor of mutant IDH1 and IDH2 enzymes in patients with IDH-mutant glioma. Tumori (2024)
Francesco Antonio Tucci, Arvydas Laurinavicius, Jakob Nikolas Kather, Catarina Eloy
The digital revolution in pathology: Towards a smarter approach to research and treatment. Tumori (2024)
Desirèe Speranza, Elena Sapuppo, Giuseppe Aprile, Alessandra Auriemma, Francesca Bergamo, Roberto Bianco, Roberto Bordonaro, Giovanni Brandi, Oronzo Brunetti, Carlo Carnaghi, Domenico Ciliberto, Saverio Cinieri, Salvatore Corallo, Ferdinando De Vita, Samantha Di Donato, Francesco Ferraù, Lorenzo Fornaro, Viola Barucca, Elisa Giommoni, Claudio Lotesoriere, Claudio Luchini, Cristina Masini, Monica Niger, Salvatore Pisconti, Ilario Giovanni Rapposelli, Lorenza Rimassa, Chiara Rognone, Maria Grazia Rodriquenz, Lidia Rita Corsini, Daniele Santin, Aldo Scarpa, Mario Scartozzi, Hector Soto Parra, Giuseppe Tonini, Giampaolo Tortora, Paolo Tralongo, Nicola Silvestris
The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric observational study of Gruppo Oncologico dell'Italia Meridionale (GOIM) in collaboration with Gruppo Italiano Colangiocarcinoma (GICO). Tumori (2024)
Fabiana Perrone, Francesco Facchinetti, Benedetta Pellegrino, Roberta Minari, Letizia Gnetti, Cinzia Azzoni, Lorena Bottarelli, Nicoletta Campanini, Juan Francisco Grau-Bejar, Anna Mingozzi, Valeria Cognigni, Marcello Tiseo
Multiple targets, germline BRCA1 mutation and HRD in a lung cancer patient: Molecular considerations and treatment decision-making. Tumori (2024)
Luigi Cerbone, Sara Delfanti, Stefania Crivellari, Antonina Maria De Angelis, Laura Mazzeo, Claudia Proto, Mario Alberto Occhipinti, Giuseppe Lo Russo, Chiara Dellepiane, Federica Biello, Irene Alabiso, Francesco Verderame, Roberta Gauna, Irene De Simone, Federica Cuppone, Sandra Petraglia, Giulia Pasello, Giovanni Luca Ceresoli, Marina Chiara Garassino, Valter Torri, Federica Grosso
Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund. Tumori (2024)
Andrea C Ferrari, Teresa Perillo, Giuseppe Maria Milano, Matteo Silva, Chiara Rutigliano, Andrea Salvo, Virginia Livellara, Massimo Conte, Luca Coccoli, Elena Amore, Marta Pierobon, Francesco Vietina, Elena Pagani Bagliacca, Marco Spinelli, Maria Speranza Massei, Valentina Massetti, Elena Legnani, Ilaria Puglisi, Giulia Zucchetti, Paola Quarello
The power of art and the powers of adolescents with cancer: Age-specific projects at Italian pediatric oncology centers. Tumori (2024)
Giulia Corrao, Luca Bergamaschi, Vanessa Eleonora Pierini, Aurora Gaeta, Stefania Volpe, Matteo Pepa, Mattia Zaffaroni, Maria Giulia Vincini, Cristiana Iuliana Fodor, Gaia Piperno, Francesca Emiro, Annamaria Ferrari, Sara Gandini, Federica Cattani, Roberto Orecchia, Giulia Marvaso, Barbara Alicja Jereczek-Fossa
Hippocampal region avoidance in whole brain radiotherapy in brain metastases: For all or for some? A real-world feasibility report. Tumori (2024)
Emanuele Crocetti, Alessandra Ravaioli, Fabio Falcini, Rosa Vattiato, Silvia Mancini, Flavia Baldacchini, Federica Zamagni, Benedetta Vitali, Chiara Balducci, Lauro Bucchi, Orietta Giuliani
How many Italian cancer patients are eligible for, and may respond to, Italian Medicines Agency-approved immune checkpoint inhibitors? Tumori (2024)

volume 110, number 1, 2024

Giulia Corrao, Luca Bergamaschi, Vanessa Eleonora Pierini, Aurora Gaeta, Stefania Volpe, Matteo Pepa, Mattia Zaffaroni, Maria Giulia Vincini, Cristiana Iuliana Fodor, Gaia Piperno, Francesca Emiro, Annamaria Ferrari, Sara Gandini, Federica Cattani, Roberto Orecchia, Giulia Marvaso, Barbara Alicja Jereczek-Fossa
Hippocampal region avoidance in whole brain radiotherapy in brain metastases: For all or for some? A real-world feasibility report. Tumori 110 (1) (2024)
Giulia Corrao, Luca Bergamaschi, Vanessa Eleonora Pierini, Aurora Gaeta, Stefania Volpe, Matteo Pepa, Mattia Zaffaroni, Maria Giulia Vincini, Cristiana Iuliana Fodor, Gaia Piperno, Francesca Emiro, Annamaria Ferrari, Sara Gandini, Federica Cattani, Roberto Orecchia, Giulia Marvaso, Barbara Alicja Jereczek-Fossa
Hippocampal region avoidance in whole brain radiotherapy in brain metastases: For all or for some? A real-world feasibility report. Tumori 110 (1) (2024)

volume 110, number 2, 2024

Emanuele Crocetti, Alessandra Ravaioli, Fabio Falcini, Rosa Vattiato, Silvia Mancini, Flavia Baldacchini, Federica Zamagni, Benedetta Vitali, Chiara Balducci, Lauro Bucchi, Orietta Giuliani
How many Italian cancer patients are eligible for, and may respond to, Italian Medicines Agency-approved immune checkpoint inhibitors? Tumori 110 (2) (2024)
Erkan Topkan, Efsun Somay, Ugur Selek
Response to Deantoni et al. Tumori 110 (2) (2024)
Emanuele Crocetti, Alessandra Ravaioli, Fabio Falcini, Rosa Vattiato, Silvia Mancini, Flavia Baldacchini, Federica Zamagni, Benedetta Vitali, Chiara Balducci, Lauro Bucchi, Orietta Giuliani
How many Italian cancer patients are eligible for, and may respond to, Italian Medicines Agency-approved immune checkpoint inhibitors? Tumori 110 (2) (2024)
Emanuele Crocetti, Alessandra Ravaioli, Fabio Falcini, Rosa Vattiato, Silvia Mancini, Flavia Baldacchini, Federica Zamagni, Benedetta Vitali, Chiara Balducci, Lauro Bucchi, Orietta Giuliani
How many Italian cancer patients are eligible for, and may respond to, Italian Medicines Agency-approved immune checkpoint inhibitors? Tumori 110 (2) (2024)
Amelia Barcellini, Chiara Cassani, Ester Orlandi, Rossella E Nappi, Federica Broglia, Maria Paola Delmonte, Silvia Molinelli, Alessandro Vai, Viviana Vitolo, Alessandro Gronchi, Gioacchino D'Ambrosio, Lorenzo Cobianchi, Maria Rosaria Fiore
Is motherhood still possible after pelvic carbon ion radiotherapy? A promising combined fertility-preservation approach. Tumori 110 (2) (2024)
Emanuele Crocetti, Alessandra Ravaioli, Fabio Falcini, Rosa Vattiato, Silvia Mancini, Flavia Baldacchini, Federica Zamagni, Benedetta Vitali, Chiara Balducci, Lauro Bucchi, Orietta Giuliani
How many Italian cancer patients are eligible for, and may respond to, Italian Medicines Agency-approved immune checkpoint inhibitors? Tumori 110 (2) (2024)
Erkan Topkan, Efsun Somay, Ugur Selek
Response to Deantoni et al. Tumori 110 (2) (2024)
Amelia Barcellini, Chiara Cassani, Ester Orlandi, Rossella E Nappi, Federica Broglia, Maria Paola Delmonte, Silvia Molinelli, Alessandro Vai, Viviana Vitolo, Alessandro Gronchi, Gioacchino D'Ambrosio, Lorenzo Cobianchi, Maria Rosaria Fiore
Is motherhood still possible after pelvic carbon ion radiotherapy? A promising combined fertility-preservation approach. Tumori 110 (2) (2024)
Amelia Barcellini, Chiara Cassani, Ester Orlandi, Rossella E Nappi, Federica Broglia, Maria Paola Delmonte, Silvia Molinelli, Alessandro Vai, Viviana Vitolo, Alessandro Gronchi, Gioacchino D'Ambrosio, Lorenzo Cobianchi, Maria Rosaria Fiore
Is motherhood still possible after pelvic carbon ion radiotherapy? A promising combined fertility-preservation approach. Tumori 110 (2) (2024)
Emanuele Crocetti, Alessandra Ravaioli, Fabio Falcini, Rosa Vattiato, Silvia Mancini, Flavia Baldacchini, Federica Zamagni, Benedetta Vitali, Chiara Balducci, Lauro Bucchi, Orietta Giuliani
How many Italian cancer patients are eligible for, and may respond to, Italian Medicines Agency-approved immune checkpoint inhibitors? Tumori 110 (2) (2024)

volume 110, number 3, 2024

Luigi Cerbone, Sara Delfanti, Stefania Crivellari, Antonina Maria De Angelis, Laura Mazzeo, Claudia Proto, Mario Alberto Occhipinti, Giuseppe Lo Russo, Chiara Dellepiane, Federica Biello, Irene Alabiso, Francesco Verderame, Roberta Gauna, Irene De Simone, Federica Cuppone, Sandra Petraglia, Giulia Pasello, Giovanni Luca Ceresoli, Marina Chiara Garassino, Valter Torri, Federica Grosso
Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund. Tumori 110 (3) (2024)
Luigi Cerbone, Sara Delfanti, Stefania Crivellari, Antonina Maria De Angelis, Laura Mazzeo, Claudia Proto, Mario Alberto Occhipinti, Giuseppe Lo Russo, Chiara Dellepiane, Federica Biello, Irene Alabiso, Francesco Verderame, Roberta Gauna, Irene De Simone, Federica Cuppone, Sandra Petraglia, Giulia Pasello, Giovanni Luca Ceresoli, Marina Chiara Garassino, Valter Torri, Federica Grosso
Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund. Tumori 110 (3) (2024)
Desirèe Speranza, Elena Sapuppo, Giuseppe Aprile, Alessandra Auriemma, Francesca Bergamo, Roberto Bianco, Roberto Bordonaro, Giovanni Brandi, Oronzo Brunetti, Carlo Carnaghi, Domenico Ciliberto, Saverio Cinieri, Salvatore Corallo, Ferdinando De Vita, Samantha Di Donato, Francesco Ferraù, Lorenzo Fornaro, Viola Barucca, Elisa Giommoni, Claudio Lotesoriere, Claudio Luchini, Cristina Masini, Monica Niger, Salvatore Pisconti, Ilario Giovanni Rapposelli, Lorenza Rimassa, Chiara Rognone, Maria Grazia Rodriquenz, Lidia Rita Corsini, Daniele Santin, Aldo Scarpa, Mario Scartozzi, Hector Soto Parra, Giuseppe Tonini, Giampaolo Tortora, Paolo Tralongo, Nicola Silvestris
The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric observational study of Gruppo Oncologico dell'Italia Meridionale (GOIM) in collaboration with Gruppo Italiano Colangiocarcinoma (GICO). Tumori 110 (3) (2024)
Desirèe Speranza, Elena Sapuppo, Giuseppe Aprile, Alessandra Auriemma, Francesca Bergamo, Roberto Bianco, Roberto Bordonaro, Giovanni Brandi, Oronzo Brunetti, Carlo Carnaghi, Domenico Ciliberto, Saverio Cinieri, Salvatore Corallo, Ferdinando De Vita, Samantha Di Donato, Francesco Ferraù, Lorenzo Fornaro, Viola Barucca, Elisa Giommoni, Claudio Lotesoriere, Claudio Luchini, Cristina Masini, Monica Niger, Salvatore Pisconti, Ilario Giovanni Rapposelli, Lorenza Rimassa, Chiara Rognone, Maria Grazia Rodriquenz, Lidia Rita Corsini, Daniele Santin, Aldo Scarpa, Mario Scartozzi, Hector Soto Parra, Giuseppe Tonini, Giampaolo Tortora, Paolo Tralongo, Nicola Silvestris
The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric observational study of Gruppo Oncologico dell'Italia Meridionale (GOIM) in collaboration with Gruppo Italiano Colangiocarcinoma (GICO). Tumori 110 (3) (2024)
Antonio Silvani, Enrico Franceschi
A new era after a long wait: Vorasidenib, an inhibitor of mutant IDH1 and IDH2 enzymes in patients with IDH-mutant glioma. Tumori 110 (3) (2024)
Anna Amela Valsecchi, Vittorio Fusco, Massimo Di Maio, Daniele Santini, Marcello Tucci, Ugo De Giorgi, Rossana Dionisio, Francesca Vignani, Saverio Cinieri
Management of cancer treatment-induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey. Tumori 110 (3) (2024)
Mutahar A Tunio, Nicki Davies, Elliot Caparros, Janis Davies, Stuart Foyle
A five-year review of chemoradiotherapy practice in anal cancer: Radiotherapy audit results from a cancer centre in Wales, UK. Tumori 110 (3) (2024)
Giulia Marvaso, Angelo Vitullo, Giulia Corrao, Maria Giulia Vincini, Mattia Zaffaroni, Riccardo Villa, Federico Mastroleo, Lukasz Kuncman, Dario Zerini, Ilaria Repetti, Chiara Lorubbio, Gennaro Musi, Ottavio De Cobelli, Barbara Alicja Jereczek-Fossa
Muscle-invasive bladder cancer in elderly and frail people: Is hypofractionated radiotherapy a feasible approach when no other local options are available? Tumori 110 (3) (2024)
Giulia Marvaso, Angelo Vitullo, Giulia Corrao, Maria Giulia Vincini, Mattia Zaffaroni, Riccardo Villa, Federico Mastroleo, Lukasz Kuncman, Dario Zerini, Ilaria Repetti, Chiara Lorubbio, Gennaro Musi, Ottavio De Cobelli, Barbara Alicja Jereczek-Fossa
Muscle-invasive bladder cancer in elderly and frail people: Is hypofractionated radiotherapy a feasible approach when no other local options are available? Tumori 110 (3) (2024)
Antonio Silvani, Enrico Franceschi
A new era after a long wait: Vorasidenib, an inhibitor of mutant IDH1 and IDH2 enzymes in patients with IDH-mutant glioma. Tumori 110 (3) (2024)

volume 110, number 4, 2024

Pamela Milito, Guglielmo Niccolò Piozzi, Mohammad Iqbal Hussain, Tommaso A Dragani, Luca Sorrentino, Maurizio Cosimelli, Marcello Guaglio, Luigi Battaglia
Effect of neoadjuvant chemoradiation on anorectal function assessed with anorectal manometry: A systematic review and meta-analysis. Tumori 110 (4) (2024)
Lauro Bucchi, Silvia Mancini, Federica Zamagni, Emanuele Crocetti, Luigino Dal Maso, Stefano Ferretti, Flavia Baldacchini, Orietta Giuliani, Alessandra Ravaioli, Rosa Vattiato, Francesca Bella, Giuliano Carrozzi, Giuseppe Cascone, Margherita Ferrante, Maria Michiara, Antonino Musolino, Rosario Tumino, Antonella Usticano, Alessandra Allotta, Sebastiano Pollina Addario, Francesco Lacarrubba, Ignazio Stanganelli, Fabio Falcini
North-south differences in incidence and surveillance of cutaneous malignant melanoma in Italy. Tumori 110 (4) (2024)
Pamela Milito, Guglielmo Niccolò Piozzi, Mohammad Iqbal Hussain, Tommaso A Dragani, Luca Sorrentino, Maurizio Cosimelli, Marcello Guaglio, Luigi Battaglia
Effect of neoadjuvant chemoradiation on anorectal function assessed with anorectal manometry: A systematic review and meta-analysis. Tumori 110 (4) (2024)
Min Zhao, Lixing Wang, Xingyu Wang, Juan He, Kuai Yu, Dan Li
Non-neoplastic cells as prognostic biomarkers in diffuse large B-cell lymphoma: A system review and meta-analysis. Tumori 110 (4) (2024)
C L Deantoni, I Dell'Oca
In reply to Topkan et al. Tumori 110 (4) (2024)
Francesco Antonio Tucci, Arvydas Laurinavicius, Jakob Nikolas Kather, Catarina Eloy
The digital revolution in pathology: Towards a smarter approach to research and treatment. Tumori 110 (4) (2024)
Andrea C Ferrari, Teresa Perillo, Giuseppe Maria Milano, Matteo Silva, Chiara Rutigliano, Andrea Salvo, Virginia Livellara, Massimo Conte, Luca Coccoli, Elena Amore, Marta Pierobon, Francesco Vietina, Elena Pagani Bagliacca, Marco Spinelli, Maria Speranza Massei, Valentina Massetti, Elena Legnani, Ilaria Puglisi, Giulia Zucchetti, Paola Quarello
The power of art and the powers of adolescents with cancer: Age-specific projects at Italian pediatric oncology centers. Tumori 110 (4) (2024)
Pamela Milito, Guglielmo Niccolò Piozzi, Mohammad Iqbal Hussain, Tommaso A Dragani, Luca Sorrentino, Maurizio Cosimelli, Marcello Guaglio, Luigi Battaglia
Effect of neoadjuvant chemoradiation on anorectal function assessed with anorectal manometry: A systematic review and meta-analysis. Tumori 110 (4) (2024)
Min Ma, Yazhi Zhu, Changkai Xiao, Ruidong Li, Xingyu Cao, Ran Kang, Xiaolan Wang, Ermao Li
Novel insights into RB1 in prostate cancer lineage plasticity and drug resistance. Tumori 110 (4) (2024)
Min Ma, Yazhi Zhu, Changkai Xiao, Ruidong Li, Xingyu Cao, Ran Kang, Xiaolan Wang, Ermao Li
Novel insights into RB1 in prostate cancer lineage plasticity and drug resistance. Tumori 110 (4) (2024)